Risk of severe upper gastrointestinal complications among oral bisphosphonate users.

BACKGROUND: Oral bisphosphonates (BPs) are the primary agents for the treatment of osteoporosis. Although BPs are generally well tolerated, serious gastrointestinal adverse events have been observed. AIM: To assess the risk of severe upper gastrointestinal complications (UGIC) among BP users by mean...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Arianna Ghirardi, Lorenza Scotti, Antonella Zambon, Gianluca Della Vedova, Luca Cavalieri D'oro, Francesco Lapi, Francesco Cipriani, Achille P Caputi, Alberto Vaccheri, Dario Gregori, Rosaria Gesuita, Annarita Vestri, Tommaso Staniscia, Giampiero Mazzaglia, Giovanni Corrao, BEST Investigators
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Public Library of Science (PLoS) 2013-01-01
Saila:PLoS ONE
Sarrera elektronikoa:http://europepmc.org/articles/PMC3857168?pdf=render
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak